These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 7910437

  • 41. Prevalence of spontaneous dyskinesia in schizophrenia.
    Fenton WS.
    J Clin Psychiatry; 2000; 61 Suppl 4():10-4. PubMed ID: 10739325
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Dyskinesia and neuroleptic exposure in elderly psychiatric inpatients.
    Sweet RA, Mulsant BH, Rifai AH, Zubenko GS.
    J Geriatr Psychiatry Neurol; 1992; 5(3):156-61. PubMed ID: 1353963
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Vitamin E treatment for tardive dyskinesia. Veterans Affairs Cooperative Study #394 Study Group.
    Adler LA, Rotrosen J, Edson R, Lavori P, Lohr J, Hitzemann R, Raisch D, Caligiuri M, Tracy K.
    Arch Gen Psychiatry; 1999 Sep; 56(9):836-41. PubMed ID: 12892048
    [Abstract] [Full Text] [Related]

  • 46. Tardive dyskinesia and impaired glucose tolerance.
    Chong SA, Mythily, Lum A, Huak CY, Kane J.
    Hum Psychopharmacol; 2002 Aug; 17(6):305-7. PubMed ID: 12404676
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Clinical forms of severe tardive dyskinesia.
    Gardos G, Cole JO, Salomon M, Schniebolk S.
    Am J Psychiatry; 1987 Jul; 144(7):895-902. PubMed ID: 2886062
    [Abstract] [Full Text] [Related]

  • 52. Tardive dyskinesia: characterization and prevalence in a statewide system.
    Bell RC, Smith RC.
    J Clin Psychiatry; 1978 Jan; 39(1):39-47. PubMed ID: 580260
    [Abstract] [Full Text] [Related]

  • 53. [Utility of quetiapine in tardive dyskinesia].
    Navarro Pacheco BV, Montejo González AL, Martín Carrasco M.
    Actas Esp Psiquiatr; 2003 Jan; 31(6):347-52. PubMed ID: 14639511
    [Abstract] [Full Text] [Related]

  • 54. Incidence of tardive dyskinesia with typical versus atypical antipsychotics in very high risk patients.
    Dolder CR, Jeste DV.
    Biol Psychiatry; 2003 Jun 15; 53(12):1142-5. PubMed ID: 12814866
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Predicting the long-term risk of tardive dyskinesia in outpatients maintained on neuroleptic medications.
    Glazer WM, Morgenstern H, Doucette JT.
    J Clin Psychiatry; 1993 Apr 15; 54(4):133-9. PubMed ID: 8098030
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Neuroleptic-related dyskinesias in children and adolescents.
    Connor DF, Fletcher KE, Wood JS.
    J Clin Psychiatry; 2001 Dec 15; 62(12):967-74. PubMed ID: 11780878
    [Abstract] [Full Text] [Related]

  • 59. Tardive dyskinesia in an outpatient population: prevalence and predisposing factors.
    Yassa R, Ananth J, Cordozo S, Ally J.
    Can J Psychiatry; 1983 Aug 15; 28(5):391-4. PubMed ID: 6138143
    [Abstract] [Full Text] [Related]

  • 60. Early-onset tardive dyskinesia in a neuroleptic-naive patient exposed to paliperidone.
    Hsu WY, Chiu NY.
    J Clin Psychopharmacol; 2013 Oct 15; 33(5):712-3. PubMed ID: 23899637
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.